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SUMMARY 
 
The differentiation of dopaminergic neurons requires concerted action of morphogens and 
transcription factors acting in a precise and well-defined time window. Very little is known about 
the potential role of miRNA in these events. By performing a miRNA-mRNA paired microarray 
screening, we identified miR-34b/c among the most upregulated microRNAs during dopaminergic 
differentiation. Interestingly miR-34b/c represses Wnt1, promotes cell cycle exit and, in embryonic 
stem cells, induces dopaminergic differentiation, down-regulating Wnt signalling. Once combined 
with transcription factors Ascl1 and Nurr1, miR-34b/c doubled the yield of trans-differentiated 
fibroblasts into dopaminergic neurons. Induced dopaminergic (iDA) cells contain dopamine and 
show spontaneous electrical activity, reversibly blocked by TTX, consistent with the 
electrophysiological properties featured by brain dopaminergic neurons.  
Our findings point to a novel role for miR-34b/c in neuronal commitment and highlight the 
potential of exploiting its synergy with key transcription factors in enhancing in vitro generation of 
dopaminergic neurons’  
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INTRODUCTION 
MicroRNAs (miRNAs) are a class of small non-coding single-strand RNA (~22 nucleotides) acting 
as post-transcriptional regulators of gene expression (Bartel and Chen, 2004). They are crucial 
players in several aspects of brain development such as neurogenesis, neuronal maturation, 
synapses formation, axon guidance and neuronal plasticity (Kapsimali et al., 2007; McNeill and 
Van Vactor, 2012). Disruption of miRNA biogenesis by genetic deletion of Dicer has been a widely 
used strategy to investigate the role of miRNAs in neurodevelopmental processes (Cuellar et al., 
2008; Davis et al., 2008; Kawase-Koga et al., 2009). Cell type-specific deletion of microRNAs 
involved in mesencephalic dopaminergic (mDA) neurons causes their progressive loss (Kim et al., 
2007), suggesting a pivotal role for miRNA in mDA neuron formation, survival and function. A 
number of laboratories attempted the identification of miRNAs involved in DA neuron 
differentiation and diseases affecting the DA system such as Parkinson’s disease (Kim et al., 2007; 
Miñones-Moyano et al., 2011; Saba et al., 2012; Tobon et al., 2012; Yang et al., 2012). 
Interestingly, recent works highlighted the importance of miRNAs, miR-135a2 in particular, in 
determining midbrain size and the allocation of prospective DA precursors by modulating the extent 
of the Wnt signaling. The latter takes place through direct regulation of Lmx1b, in a context where 
the excessive Wnt signaling has been shown to lead to improper DA specification (Joksimovic and 
Awatramani, 2014; Nouri et al., 2015). Lmx1b is necessary to induce/maintain Wnt1 expression at 
the Midbrain-Hindbrain Boundary (Adams et al., 2000; Guo et al., 2007; Sherf et al., 2015) and 
together with Lmx1a regulates mDA progenitor proliferation in part through the regulation of Wnt1 
(Panhuysen et al., 2004). Thus manipulation of Wnt signaling has become an attractive strategy to 
define new in vitro differentiation protocols to increase the fraction of DA neurons. 
In addition, miRNAs are also emerging as possible components in both direct and indirect cell 
reprogramming strategies. Specific miRNAs are able to potentiate transcription factors (TFs)-
mediated conversion of mouse embryonic fibroblasts (MEFs) into induced pluripotent stem cells 
(iPSCs) (Judson et al., 2009; Subramanyam et al., 2011). While two miRNAs, miR-9/9* and miR-
124, are able to convert fibroblasts into neurons (iNs) (Yoo et al., 2011) or specific subset of 
neurons if combined with defined transcription factors (Victor et al., 2014), to date, the ability of 
miRNAs to enhance DA-transdifferentiation (Caiazzo et al., 2011) is still largely unexplored. 
miR-34b-5p and miR-34c-5p (hereafter renamed miR-34b/c) belong to a large family of 
microRNAs that include miR-34a-5p and the miR-449 cluster (449a-5p, and c-5p). They all share 
the same seed sequence and are considered having overlapping roles. More recently it has been 
shown that miR-34a/b/c share only 20% of targets suggesting that individual miR-34 family 
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members exert largely unique roles (Navarro and Lieberman, 2015). Interestingly, miR-34b/c 
expression was altered in Alzheimer’s disease (Zovoilis et al., 2011), Huntington’s disease (HD) 
(Gaughwin et al., 2011) and in Parkinson’s disease (PD) (Miñones-Moyano et al., 2011). In 
addition, miR-34b/c was found significantly downregulated in brain areas of PD patients with 
different degrees of pathology, prior to the appearance of motor dysfunction (Miñones-Moyano et 
al., 2011).  
In this work, we identified the miR-34b/c cluster as an additional modulator of the Wnt signaling 
pathway.  Enforced expression of miR-34b/c significantly increases in vitro differentiation of DA 
neurons. We show that miR-34b/c is able to directly bind the Wnt1 3’UTR and to regulate its 
expression. Consistently, overexpression of miR-34b/c leads to reduction of Wnt1 and Lmx1b in 
DA differentiated mouse embryonic stem cells (mES). In combination with the iDA-specific 
transcription factors Ascl1 and Nurr1 (Caiazzo et al., 2011), miR-34b/c doubles the 
transdifferentiation efficiency, leading to the generation of functional iDA neurons with 
characteristic electrophysiological properties. 
 
RESULTS 
The Wnt pathway is downregulated during in vitro differentiation of mesencephalic DA 
neurons 
To investigate the roles of miRNAs in dopaminergic neuron fate specification, we performed a 
microarray screening and measured the expression of both mRNAs and miRNAs during mDA 
differentiation of epiSC cells using a monolayer differentiation (MD) method developed previously 
(Jaeger et al., 2011). As control, the same cells were differentiated in the basal condition without 
SHH and FGF8, leading to the production of mostly GABAergic neurons. Samples were harvested 
at day 9 (d9) and d14 MD (Figure 1A) and RNAs processed for gene expression on mRNAs and 
miRNAs by microarray. To evaluate the activation of specific differentiation programs we analyzed 
the expression of genes involved in developmental fate specifications and neuronal maturation at d9 
and d14 MD in the DA and control samples. By comparing both conditions we did not identify any 
difference in the expression of marker for anterior/posterior identity or other neuronal subtypes such 
as  GABAergic, glutamatergic or cholinergic neurons at d9 and d14. DA associated transcripts were 
upregulated from d9 to d14 (Figure 1B). The induction of mDA fate was further confirmed by 
following the expression of selected DA markers such as TH, Nurr1, Pitx3, Dmrt5, Foxa2a and 
Lmx1a. All these gene markers showed a robust upregulation during the entire differentiation 
protocol, in cultures treated with SHH and FGF8 (Figure 1C).  
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In contrast, general neuronal markers, such as Tubb3, Mash1, Map2 and NGN2, have a similar 
expression profile in both DA and control conditions (Figure 1D). Consistent with the transcript 
analysis, immunostaining for TH and GFP (for Pitx3-GFP) at the end of the differentiation protocol 
confirmed the generation of DA neurons (Figure 1E). 
By comparing gene expression profiles data at day 9 and day 14 (d9 MD/d14 MD) in SHH/FGF8 
treated samples (david.ncifcrf.gov) (Huang et al., 2007a), we noticed that the Wnt signaling 
pathway becomes one of the most affected KEGG (Kyoto Encyclopedia of Genes and Genomes) 
pathway along the DA differentiation (Figure 2A). 
We have previously performed microarray screening comparing the floor plate (ventral midbrain, 
DA) versus basal plate (non-DA) transcripts at three embryonic time points: E9.5, E10.5 and E12.5 
(Gennet et al 2011). Re-analysis of this dataset revealed that only 5 Wnts (Wnt1, Wnt5a, Wnt5b, 
Wnt7a and Wnt9a) are expressed at E9.5 but their expression decrease progressively till E12.5 
(Figure 2B). These five genes were among the most upregulated Wnts in our microarray dataset 
from epiSC at the differentiation stage d9 and d14 MD. Of which, Wnt5b, Wnt7a and Wnt9 show a 
similar trend of downregulation from d9 to d14 MD in both control and DA differentiation cultures. 
However, the transcripts of Wnt1 and Wnt5a behave differently. Wnt1 was downregulated from d 9 
to d14 in DA cultures but up-regulated in the controls while Wnt5a showed the opposite trend 
(Figure 2C and Figure S1A). The reduction of Wnt1 in DA cultures was confirmed by independent 
RT-PCR analysis performed between d9 and d14 (Figure S1B). A similar induction, although less 
pronounced, was observed for Lmx1b (Figure S2B), a transcription factor known to be involved in 
early stages of MHB formation (Guo et al., 2007) and was recently associated to Wnt1 as part of a 
regulatory loop together with miR-135a-2-5p (Anderegg et al., 2013). 
Interestingly, most of the genes that positively affect the Wnt1 signaling were downregulated at d14 
MD, including Wnt1 itself. In contrast some known inhibitors of the Wnt pathway, such as Gsk3ß 
or Ctnnbip1, were upregulated (Figure 2D and scheme in 2E).  
These data suggest that a precise regulation of the Wnt signaling during DA differentiation is 
needed to achieve proper generation of DA neurons. 
 
miR-34b/c targets Wnt1 and is enriched in purified Pitx3-GFP+ DA neurons 
To test the hypothesis that negative regulation of Wnt1 could be achieved through the action of 
miRNAs, we screened miRNA-specific array data for miRNAs upregulated during DA 
differentiation. By using available miRNA target prediction tool (targetscan.org/mmu_71/) 
(Agarwal et al., 2015) we scanned for all miRNAs upregulated at d14 DA cells compared to the 
controls which are predicted to bind to the 3’UTR of downregulated genes in the Wnt signaling 
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pathway. miR-34b/c and miR-148a-3p, both scored in our list with 18 and 13 predicted binding 
sites, respectively(Figure 3A), and were predicted to directly target Wnt1 (Figure 3B). Pitx3-GFP is 
a mouse line in which the midbrain dopamine neurons are exclusively labelled by the knock in GFP 
reporter (Zhao et al. 2004).  Interestingly both miR-34b/c and miR-148a-3p were enriched in FACS 
purified GFP+ cells obtained from embryonic day 12.5 and 13.5 Pitx3-GFP embryos (Figure 3C), 
confirming their expression in mesencephalic DA neurons in vivo. Hence, we investigated if miR-
34b/c and miR-148a-3p could act as post-transcriptional regulators of Wnt1. To this purpose we 
performed Luciferase assay by transfecting plasmids expressing both miRNAs with a pmiR-reporter 
containing Wnt1-3’UTR in HeLa cells. Both miR-34b/c and miR-148a-3p were able to significantly 
reduce Luciferase activity (34,6% and 20 %, respectively). The effect was abolished after mutation 
of the predicted binding site for miR-34b/c but not for miR-148a-3p, suggesting that only miR-
34b/c effectively binds to its predicted site at the Wnt1-3’UTR (Figure 3B,D). 
To further confirm that miR-34b/c is expressed during DA differentiation, we used a dual-
fluorescent green fluorescent protein (GFP)-reporter/monomeric red fluorescent protein (mRFP)-
sensor (DFSP) plasmid (De Pietri Tonelli et al. 2006), which allows the detection of microRNA at 
single cell resolution. We cloned a tandem cassette complementary to miR-34b/c in the 3’UTR of 
the mRFP sensor (pDSV3-34) or mutated in the region corresponding to the “seed sequence” of 
miR-34b/c (pDSV3-34mut). This approach has been described as very efficient for monitoring the 
endogenous expression of microRNAs both in-vitro and in-vivo. The expression of miR34b/c was 
evaluated in proliferating and differentiated mES transfected with pDSV3-34, 72 hours after 
transfection. When mES were growth in differentiating condition the expression of the mRFP-
sensor was strongly reduced (left column in Figure 3E). In proliferating conditions both GFP and 
mRFP-sensor were, instead, clearly expressed (Figure S2). Such effect was no longer observed with 
pDSV3-34mut (Figure 3E). 
The endogenous miR-34b/c was also able to downregulate the expression of the mRFP-sensor 
containing the entire Wnt1-3’UTR sequence downstream the CDS (pDSV2-UTR). A reduction for 
the mRFP-sensor was clearly visible in mES transfected with pDSV2-UTR 72 hours after 
transfection (second right column, Figure 3E). Mutation in the binding site for miR-34b/c (pDSV2-
UTRmut) did not affect the mRFP-sensor expression (right column; Figure 3E). 
 
Overexpression of miR-34b/c downregulates Wnt1 and enhances mES DA differentiation 
Our data strongly suggest that miR-34b/c has a role in DA neuron differentiation. To further 
corroborate this finding we cloned 1000bp genomic DNA encompassing the miR-34b/c cluster into 
an inducible lentiviral vector upstream of an Ires-GFP sequence (lenti-miR34b/c-Ires-GFP) and 
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overexpressed the miR-34b/c cluster during in vitro DA differentiation of mES cells. mES were 
infected with an inducible lenti-miR34b/c-Ires-GFP (or with an inducible Lenti-GFP as control) 
treated with doxycycline for one-day and FACS purified for GFP. GFP+ cells were amplified in 
absence of doxycycline and then differentiated towards the DA phenotype in the presence or 
absence of doxycycline for 14 days (see scheme Figure 4A). At the end of the differentiation, the 
expression of miR-34c, was enriched sixteen-fold (Figure 4B). While no difference was observed in 
GFP+ mES cells infected with a Lenti-GFP (Figure 4B).  
The overexpression of miR-34b/c cluster induced a marked downregulation in the mRNA levels of 
both Wnt1 and Lmx1b (Figure 4C). Consistent with the RNA data immunostaining revealed a 
significant reduction of Lmx1b+ cells (Figure S3). In parallel, we observed reduced amount of 
mRNAs for Lef1 and Axin2, thus supporting a role of miR-34b/c as regulator of the Wnt signaling 
(Figure 4C). The overexpression of miR-34b/c also promoted DA differentiation. Indeed, we found 
a significant upregulation of DA markers such as TH, DAT, Vmat2 and Pitx3 (Figure 4D). In 
addition, miR34b/c overexpression resulted in ~ 60% increase in the number of TH+ cells compared 
to control cultures (Figure 4E-F).  
 
miR-34b/c enhances fibroblasts transdifferentiation into iDA neurons. 
It has been shown that direct reprogramming of mouse embryonic fibroblasts (MEF) (Caiazzo et al., 
2011) represents a powerful source of DA neurons (iDA), useful for functional studies and cell 
replacement approaches. Hence, we further investigated if miR-34b/c could increase the yield of 
DA neurons in such experimental paradigm. To this purpose, MEF derived from mice expressing 
the GFP under the control of the TH promoter (Sawamoto et al., 2001) were infected with inducible 
lentiviruses expressing miR-34b/c cluster in combination with the reprogramming transcription 
factors Ascl1 and Nurr1 (renamed also A, N) (Caiazzo et al., 2011).  
The expression of miR-34b/c in combination with AsclI and Nurr1 was induced one day after the 
infection by adding doxycycline to the culture media. Cells were then differentiated for fourteen 
days (d14 MD) before analyzing the amount of TH+ and GFP+ cells. FACS analysis revealed that 
the combination of miR-34b/c with Ascl1 and Nurr1 (AN vs AN+34b/c) increases the number of 
GFP+ cells from 10.1% ± 1.7% to 19.5% ± 2.4% (Figure 5A,B) while miR-34b/c alone or in 
combination with Ascl1 was unable to induce GFP expression (unpublished result). Such a 
difference was further verified by increased TH mRNA (Figure 5H) and the number of TH+ cells 
following quantification of captured images (Figure 5C-E).  
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The addition of miR-34b/c affects terminal differentiation of DA neurons. Indeed the expression of 
late DA-specific markers such as DAT and Vmat2 were enriched, at mRNA level, when miR-34b/c 
was combined with Ascl1 and Nurr1 (AN34 vs AN in Figure 5I,J).  
To understand if the effect of miR-34b/c occurs by affecting cell cycle progression we infected the 
neuronal cell line A1 (Colucci-D’amato et al.1999) with an inducible lenti-miR34b/c-Ires-GFP 
(lenti-miR34b/c-Ires-GFP) or with a lenti-GFP as control and analyzed FACS purified GFP+ cells 
by quantitating of DNA content. In cells expressing miR-34b/c (lenti-miR34b/c), 48 hours after 
infections, the amount of cells in G0/G1 was increases to 74,5% ± 3%, while in control cells (lenti-
GFP) it was of  61% ± 1% (Figure S4A-B). 
Since Ascl1 is known to be capable of activating Wnt signaling (Rheinbay et al., 2013), we 
hypothesized that the effect we observed could occur via the inhibition of Wnt1 and its downstream 
signaling. To verify this hypothesis we infected MEF derived from TH-GFP with Ascl1, Nurr1 and 
miR-34b/c in the presence of CHIR99021 (chiron), a selective inhibitor of Gsk3ß that can mimic 
Wnt activation. We found that while chiron did not alter the level of Wnt1 (AN34C in Figure 5F), it 
elicited a strong upregulation of Lef1 (AN34C in Figure 5G), suggesting an activation of Wnt 
signaling as expected. Such effect was accompanied by a significant reduction in both the number 
of TH+ neurons (AN34C in Figure 5C, D, H) and the transcript level of several late DA marker 
genes s such as Vmat2 and DAT (AN34C in Figure 5H-J). Thus, chiron induced Wnt pathway 
activation blocks the DA promoting effect of miR-34b/c.  
 
miR-34b/c programmed iDA cells are functionally active 
MEF-derived iDA by miR-34b/c direct reprogramming contains also higher amounts of dopamine 
as shown after staining with an anti-DA antibody (Figure 6A-B). Higher amount of double positive 
(DA+, TH-GFP+) cells (16.1% ± 2.3% vs 6.9% ± 2.5%) were identified when miR-34b/c was 
included into the reprogramming cocktail (AN34 vs AN) (Figure 6B). 
To directly investigate the state of maturation of miR-34b/c derived iDA we measured action 
potential and performed targeted whole-cell electrophysiological recordings At functional level TH-
GFP+ cells, derived with miR-34b/c, displayed active neuronal properties. In extracellular 
recordings, we recorded spontaneous action potential firing at 3.93 ± 2.28 Hz in 4 cells. These 
events, were reversibly blocked by TTX (1µM), suggesting that they were mainly mediated by 
sodium currents  (Figure 6C).  
In whole cell recordings, depolarizing current injection of increasing amplitudes from a holding 
potential of -55 /-60 mV (1 sec, Figure 6D) evoked trains of action potentials in five cells, that were 
completely blocked by TTX (Figure 6D, right), similar to those seen in ex vivo dopaminergic 
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neurons, In response to the same protocol, another group of cells displayed membrane 
depolarization that did not reach the threshold for action potential generation (not shown).  
In voltage clamp recordings (Figure 6C, Vh= - 60 mV), we applied hyperpolarizing voltage steps (to 
-120 mV, 20 mV increment) to activate the hyperpolarization activated inward current, Ih, largely 
expressed by dopaminergic neurons of the substantia nigra pars compacta (Grace and Onn, 1989; 
Mercuri et al., 1995) and to a less extent by some neurons of the ventral tegmental area (Krashia et 
al., 2017). Only two out of the 25 recorded GFP+ cells displayed a small Ih current (Figure 6E) and 
a sag potential in response to hyperpolarizing current injections in current clamp mode (Figure 6G). 
Panel H (top) shows voltage-gated Na+ and K+ currents elicited by depolarizing voltage steps (-30 
to +60 mV, 10 mV increment, 300 msec). Voltage-dependent sodium currents are more clearly 
visible at expanded time scale in Panel E, bottom. Taken together these data confirm that miR-
34b/c-derived iDA behave as functional active dopaminergic neurons. 
 
DISCUSSION 
miRNAs affect Wnt signaling. 
In the midbrain Wnt signaling is required for dopaminergic neurongenesis and among the multiple 
canonical Wnts, Wnt1 and Wnt5a have a well-established role in promoting DA differentiation. 
(Arenas 2014). The progressive down-regulation of Wnt1 during the maturation of DA neurons 
leads our hypothesis that microRNAs could be part of this process. Along the same idea it was 
recently shown that restriction of Wnt1 and the downstream Wnt signaling occurs during mDA 
development and is achieved by a feedback loop including miR-135a-2-5p that acts by repressing 
Lmx1b, and lowering Wnt1/Wnt signaling (Anderegg et al., 2013). Interestingly miR-135a-2-5p 
was the microRNA with the higher number of predicted targets among the genes associated with 
Wnt pathway which were down-regulated at the late phases of our DA-differentiation experiment 
(between d9 and d14 MD), confirming the relevance of our analysis aimed to identify novel 
candidate miRNAs capable of modulating Wnt signaling during DA differentiation. Of note, recent 
data uncovered an essential function of the miR-34/449 family in coordinating cell proliferation and 
differentiation (Otto et al. 2017). It id of general consensus that in the brain miRNAs confer 
robustness to specific developmental processes and contribute to the maturation of specific neuronal 
circuits (Amin et al., 2015; Choi et al., 2008; Conaco et al., 2006; Cuellar et al., 2008; Tan et al., 
2013, Stark et al. 2011). It is possible that miR-34b/c acts, at least in part, along the same axis by 
restraining Wnt signaling in the midbrain, thus facilitating cell cycle exit and allowing progenitor 
differentiation towards mature DA neurons. 
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miR-34b/c targets Wnt1 and promotes DA differentiation. 
By in silico analysis we identified miR-148a-3p and miR-34b/c as microRNAs predicted to target 
Wnt1 3’UTR. Although both are enriched in FAC sorted DA neurons only miR-34b/c binds the 
Wnt1 3’UTR and represses luciferase activity. This finding differs from a previous report (Shi et 
al., 2015) and could be explained either by the different cellular context or the cloning strategy we 
used. Indeed instead of the 8bp corresponding to the precise miRNA’s seed complementary region 
we cloned almost the entire Wnt1 3’UTR sequence (~900 bp) downstream the luciferase reporter 
coding sequence. Therefore, our result could reflect a more in vivo like situation representing the 
real difference in targeting efficiency for both miR-34b/c and miR-148a-3p. 
miR-34b/c was previously shown to be downregulated in postmortem brain of PD patients at 
different stages of the pathology (Miñones-Moyano et al., 2011), although few papers described the 
involvement of miR-34b/c in DA neurons. No DA related phenotypes were reported to the miR-
34b/c knock-out mice (Comazzetto et al., 2014; Concepcion et al., 2012). The may be explained by 
the redundancy between the miR-34 family that include three members of miR-449 (a, b and c), in 
additional to miR-34a, b and c. It is plausible that in vivo fine-tuning of the Wnt signaling might 
require the action of several miRNAs targeting simultaneously different actors of the pathway. In 
this view, it is not surprising that deletion of a single gene cluster has limited or no effects, in-vivo, 
on DA differentiation. 
While the function of miR-34a in regulating Wnt signaling has been shown both in cancer 
progression and development (Kim et al., 2013; Kim et al., 2011), the involvement of miR-34b/c in 
this pathway has been largely neglected mainly because of the assumption that miRNAs sharing 
identical seed sequences target the same genes. It is now clear, however, that the role of individual 
miRNA should be considered relatively to the cellular context and that sequence determinants 
outside the seed might profoundly affect miRNA binding through a undefined mechanism. This 
concept is particularly evident for miR-34 family members (miR-34s). Indeed the overexpression of 
each miR-34 identified only few common targets (Navarro and Lieberman, 2015) and similarly 
proteomic profiles of cells overexpressing miR-34a and c are completely different (Ebner and 
Selbach, 2014). We propose that miR-34b/c acts by facilitating cell cycle exit through Wnt 
signaling inhibition, similarly to that of miR-218 in cardiac and osteoblast differentiation (Hassan et 
al., 2012; Wang et al., 2016).  
 
miR-34b/c potentiates iDA reprogramming 
Direct reprogramming has been used to achieve differentiation of fibroblasts into specific subtypes 
of mature neurons (Vierbuchen et al., 2010) and is considered a promising approach both in term of 
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regenerative medicine and studies of human diseases. For dopaminergic neurons this result has been 
achieved by combinatorial expression of early and late DA TFs such as Ascl1, Lmx1a and Nurr1 
(Caiazzo et al., 2011). miRNAs are considered a very promising additional tool to increase the yield 
of specific neuronal populations as it was shown by miR-9 and miR-124 (Victor et al., 2014). A 
similar mechanism may be proposed also for miR-34b/c, which increases DA differentiation 
efficiency facilitating cell cycle exit, as also shown by the upregulation of a potent cyclin-dependent 
kinase inhibitor p21 (unpublished data). The expression of miR-34b/c during the differentiation 
phases in combination with Ascl1 and Nurr1 represses proliferation and promotes terminal 
differentiation through the down-regulation of Wnt1, which was maintained at high level by 
constant expression of Ascl1 (Rheinbay et al., 2013). The importance of miR-34b/c in cell cycle 
progression has emerged also in previous reports that placed miR-34s downstream of p53 (Kim et 
al., 2011). However silencing of p53 has been used as an approach to increase the yield of iN (Jiang 
et al., 2015). Our results are not in contraddition with this view since we believe that suppression of 
p53 activity intervene in the initial phase of transdifferentiation by enhancing the generation of 
neuronal precursors. Then a second level of regulation might be required to shut down molecular 
programs to counteract differentiation. In dopaminergic neurons this is the case of miR-124 (Jiang 
et al., 2015) and miR-34b/c that facilitate the generation of functional DA neurons by silencing the 
Wnt pathway.  
Taken together our findings show that the achievement of  functional DA neurons requires the 
control over time of proliferative stimuli (such as Wnt signaling) that are actually essential during 
early progenitor differentiation. The neuronal differentiation of the DA cells has been also validated 
by the electrophysiological experiments, which have detected repetitive spontaneous activity and 
voltage-dependent current. These properties are consistent with a neuronal phenotype (Caiazzo et 
al., 2011).  Therefore, we believe that microRNAs are very good candidates for neuronal 
differentiation. They may act as molecular switch to facilitate the transition progenitors-mature DA 
neurons, as we show here for miR-34b/c. It is plausible that other miRNAs are involved in the DA-
differentiation process through the regulation of different pathways. It will be thus compelling to 
attain their identification in order to further understand the process of midbrain DA differentiation 
and increase the overall yield of DA neurons as well as to improve their features in term of both 
molecular and physiological properties. 
 
EXPERIMENTAL PROCEDURES  
Ethics Statement: All procedures involving mice were carried out in strict accordance with national 
and European law. 
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EpiSC neural differentiation in vitro: Dopaminergic differentiation of epiSCs was performed as 
previously described (Jaeger et al., 2011). Briefly epiSC were plated in N2B27 medium 
supplemented with bFGF and activin on a 12-wells plate coated with Fibronectin (15 µg/ml  in 
PBS) for 30 min at 37°C. Once cells reach 60 to 80% of confluence the medium was switched to 
N2B27 medium, without bFGF and Activin (this day is referred to as day 0 or MD0 in our 
differentiation protocol). During the first two days of DA neuron differentiatiion, N2B27 was 
supplemented with 1µM  FGF/ERK inhibitor PD0325901 (PD03) . On MD1 half of the media was 
replaced with fresh media. On MD2 cells were passaged onto a new 12-wells plate previously 
coated with Poly-L-lysin (15µg/ml in PBS)/Laminin (20µg/ml in PBS). SHH (200 ng/ml) and FGF8 
(100ng/ml) were added to the medium from MD5 to MD9. Control cells were maintained in basal 
medium N2B27 till the end of the in vitro differentiation protocol.  
Immunocytochemistry: The following primary antibody were used: anti-Tuj1 1:1000 (Covance), 
anti-TH 1:1000 (Chemicon); anti-Lmx1b was gift from Dr. Antonio Simeone, anti-GFP (Thermo). 
Dopamine staining was performed with an anti-dopamine specific antibody (ImmuSmol) 
accordingly to manufacture instruction. 
Images quantification: Images were acquired using a Leica TCS SP5 confocal microscope. 
Quantification was performed either by using the cell counter plugin in the ImageJ software on 
randomly selected fields either by performing a pixel analysis quantifications with a custom made 
ImageJ plugin (rsb.info.nih.gov/ij/download/). In both cases quantification was performed from at 
least 3 independent experiments.  
Fluorescence-activated cell sorting (FACS): Transdifferentiated MEF obtained from TH-GFP mice 
and mouse ES cells were trypsinized washed and sorted with a BD FACSAria II. Cells were 
collected in Tri-Reagent (Sigma) for RNA extraction or in cell culture medium for following 
amplification. Freshly dissected VMs were dissociated using a Papain dissociation system 
(Worthington). Pitx3-GFP+ cells were sorted on a Cytopeia Influx Cell sorter or BD FACS Aria III 
using previously described settings (Jacobs et al., 2011) and collected in RNAlater (Invitrogen).  
Microarray data analysis: Gene Ontology (GO) and pathway analysis were performed using 
DAVID functional annotation tool (https://david.ncifcrf.gov) (Huang et al., 2007b) in order to find 
over-represented biological themes. Default DAVID parameters were used. To identify the 
pathways altered, the online tool available from Kanehisa laboratories, KEGG Mapper was used 
(Kanehisa et al., 2010). Putative miRNA-mRNA interaction: For the identification of miRNA 
responsive elements within the 3’UTRs of protein coding genes, we used TargetScan algorithm 
(Lewis et al., 2005).  
RNA extraction and reverse transcription: RNA was extracted from cells and tissues using the TRI-
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Reagent (Sigma). RNA was treated with DNAase I (Ambion) to eliminate possible DNA 
contaminations. The yield and the integrity of RNA were determined by spectrophotometric 
measurements and by agarose gel electrophoresis, respectively. 1μg of RNA was reverse 
transcribed using random hexanucleotides as primers (NEB) and 400 units of SuperScript III (Life 
Technologies). RNAaseH was added to remove remaining RNA (2U/µl; Life Technologies). For 
miRNAs expression analysis we used the miRVana miRNA isolation strategy to recover large 
mRNAs and ribosomal RNAs down to 10-mers small RNAs, following the manufacturer 
instructions. qPCR: the analysis was carried out on triplicate samples for each experiment and 
processed separately.  
Lentivirus preparation and viral infection: cDNAs for mAscl1, mNurr1-3xFLAG and 983 bps 
encompassing the pri-miRNA-34b/c cluster were cloned into Tet-O-FUW lentiviral vectors under 
the control of the tetracycline operator.  
Lentiviruses were packaged in HEK 293T cells as previously described (Caiazzo et al., 2011).  
Genes expression was tested by Real Time PCR, while miRNA levels were measured by TaqMan 
assay. Infections were performed in combination of rtTA transactivator viruses supplied with 
doxycycline (2µg/ml, Clontech). 
Luciferase assay: The 3’UTR-containing pmiR-Report was co-transfected with the Tet-O-FUW 
miRNA over-expressing vector and the rtTA expressing vector in HeLa cells. To quantify the 
transfection efficiency a pRL-SV40 Renilla Luciferase Reporter Vectors (Promega) was also used. 
For each assay, controls with the empty pmiR-Report vector or without over-expressing any 
miRNA were performed.  
Cell cycle progression: Cell cycle analysis was performed in mes-c-myc-A1 cells, infected with 
Tet-O-FUW-GFP or Tet-O-FUW-miR34b/c-IRES-GFP, and cultured in presence of FBS for 24, 36 
and 48 hours after lentiviral activation by doxycycline. Then propidium iodide (PI; 20 µg/mL, 
Sigma-Aldrich) was added 30’ before samples processing with FACS BD Canto. 
Induced dopaminergic (iDA) neurons generation: MEFs are isolated from E14.5 TH-GFP mice 
embryos. Head, vertebral column, dorsal root ganglia and all internal organs were removed and 
discarded. The remaining embryonic tissue was manually dissociated and incubated in 0.25% 
trypsin (Sigma) for 10–15 min. Cells from each embryo were plated into a 15 cm tissue culture dish 
in MEF media [DMEM (Life Technologies) containing 10% fetal bovine serum (FBS; Hyclone), 
non-essential amino acids (Life Technologies), sodium pyruvate and penicillin/streptomycin (Life 
Technologies)]. MEFs were infected with Tet-O-FUW-mAscl1, Tet-O-FUW-mNurr1 and Tet-O-
FUW-miRNAs lentiviruses in MEF media. 16–20 h after infection cells were switched into fresh 
MEF media containing doxycycline (2µg/ml, Sigma). After 48 h the media was replaced with 
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neuronal inducing media [DMEM/F12 (Life Technologies), B27 (Life Technologies) and 
penicillin/streptomycin (Life Technologies)] containing doxycycline. The medium was changed 
every 2–3 days up to 14 days. 
Dual fluorescent reporter sensor: DFRS plasmids were kindly provided by Prof. Wieland B. 
Huttner. Cloning strategy was performed as previously described (De Pietri Tonelli et al. 2014)  
Electrophysiology recordings: Whole-cell patch-clamp and conventional single-unit extracellular 
recordings were performed accordingly to published procedures (Guatteo et al., 2013, 2016) from 
visually identified TH-GFP+ cells plated on glass coverslips at 12-16 days post-infection. A single 
coverslip was placed into a recording chamber (0.6 mL) of an upright microscope (BX51WI; 
Olympus) and continuously perfused (1 mL/min) with artificial cerebrospinal fluid (aCSF) 
containing (in mM): 126 NaCl, 2.5 KCl, 1.2 MgCl2, 1.2 NaH2PO4, 2.4 CaCl2, 10 glucose, and 24 
NaHCO3, 290 mOs/L, gassed with 95% O2–5% CO2, pH 7.4. The presence of eGFP in the cells 
was verified by means of a 40 X water-immersion objective when excited with UV light at 480 nm 
(emission filter, 510 nm) provided by a monochromator (Polychrome IV; Till Photonics GmbH, 
Munich, Germany). Emitted light was detected by a CCD camera (EvolveTM; Photometrics, Tucson, 
AZ).  
Conventional single-unit extracellular recordings were performed in cell attached configuration 
after a giga seal was established by means of capillaries pulled from thin-wall filamented glass 
(TW150F4; World Precision Instruments, Germany) and filled with intracellular solution (see 
below for composition). Spikes were recorded during the I = 0 mode of a MultiClamp 700B 
amplifier with high-pass (0.5 Hz) and low-pass filtering (1 kHz), digitized at 20 kHz sampling rate 
with Digidata 1322A and computer saved using Clampex 9 (all from Molecular Devices, 
Sunnyvale, CA).  
Whole cell patch-clamp recordings were performed with thin-wall pipettes (6–8 MΩ) filled with a 
solution containing (in mM): 125 K-gluconate,10 KCl, 10 HEPES, 1 MgCl2, 4 ATP-Mg2, 0.3 GTP-
Na3,0.75 EGTA, 0.1 CaCl2, 10 Phosphocreatine-Na2 (pH 7.2,~280 mOsm). For the experiments in 
current-clamp mode, the cells were held at −55/-60 mV with a constant DC current. Action 
potentials were evoked by injecting depolarizing currents.  
Membrane currents were recorded in voltage clamp mode at -60 mV holding potential, were filtered 
at 1–4 kHz using the amplifier’s in-built lowpass filter, digitized with Digidata 1322A and 
computer-saved at a sampling rate of four times the filter frequency. No liquid junction potential 
correction was applied. 
Statistical Analysis: All the statistical analyses were performed using GraphPad Prism (GraphPad 
Software). All the experiments have been replicated at least three times. Significance of differences 
 15 
was assessed by One Way ANOVA followed by Newmann-Keuls post-hoc test for intergroups 
comparisons or by Student’s t-test when cultures were compared to the corresponding control or 
with vehicle.  
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FIGURES LEGENDS 
 
Figure 1 – miRNAs-mRNAs profiling in epiSC differentiated towards the dopaminergic 
phenotype. (A) Schematic representation of the protocols used to profile miRNA and mRNA 
expressions during DA differentiation. RNA samples were harvested in triplicate on d9 MD and d14 
MD from both protocols. (B) The expression of genes representative for specific developmental fate 
and for different neuronal populations is shown at d9 and d14 MD. Data are represented as 
log(DA/Ctrl). (C) qPCR for the expression of DA-specific marker, or (D) general neuronal markers 
over the differentiation protocol from d6 MD to d14 MD. All qPCR data have been normalized to the 
average of the reference gene Hmbs. The highest value for each gene (among both +SHH/FGF8 and 
-SHH/FGF8 samples) was set to 1. All other values are expressed as a ratio of 1. Data represent 
mean± s.e.m from three independent experiments. (E) Pitx3-GFP epiSC at d14 MD differentiated in 
presence (+) or absence (-) of SHH and FGF8 and immunostained for TH (Red) and GFP (Green) 
expression. Higher magnification images for TH are in yellow. DAPI is shown in blue. Scale bar is 
200μm and 100μm respectively for low and high magnification images. 
Figure 2 – Wnt1 and the wnt pathway are downregulated during DA differentiation of epiSC. 
(A) Top ten categories of KEGG pathway associated with differentially expressed genes between d9 
MD and d14 MD of the dopaminergic differentiation protocol (+SHH/FGF8). The p-values were 
calculated using hypergeometric test and corrected by Benjamini-Hocheberg adjustment. (B) Relative 
expression of the most expressed Wnt genes in Floor Plate and Basal Plate during embryos 
development, from E9.5 to E12.5. (C) The trend of expression in epiSC differentiation from d9 to 
d14 is shown for the most expressed Wnt genes in epiSC differentiation. (D) Hierarchical clustering 
of mRNA in d9 MD and d14 MD of dopaminergic differentiation (+SHH/FGF8) and control (- 
SHH/FGF8). The cluster was built according to the expression profiles of differentially expressed 
genes of Wnt signaling pathway. The key color bar indicates that the genes’ expression levels 
increased from red to green. Boxes highlight the most significant differences. The most representative 
genes of Wnt pathway have been reported on the right of the heatmap. (E) Cartoon with the most 
important genes involved in the Wnt pathway. Arrows in grey represent genes trend from array data. 
Figure 3 – miR-34b/c targets Wnt1 and is expressed in DA neurons. Upregulated miRNAs 
obtained by comparing dopaminergic (+SHH/FGF8) versus control protocols (-SHH/FGF8) both at 
d9 MD and d14 are shown in (A). For each miRNA is reported the number of predicted targets 
identified among the down.regulated Wnt signaling genes according to TargetScan algorithm. 
miRNAs selected for further investigation and miR-135a2 are highlighted. 
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(B) Schematic diagram of the Wnt1 3’UTR reporting conserved miRNAs binding sites. The wild type 
(3UTR WT) and mutated (3UTR M) seed sequences for miR-34b/c and miR-148a-3p are highlighted. 
(C) TaqMan assay for the expression of miR-34c and miR-148a-3p in FACS purified Pitx3-GFP+ and 
Pitx3-GFP- cells at embryo stage E12.5, E13.5 and E16.5. Data are normalized to the average of the 
reference sno-202 and represent mean± s.e.m of three independent experiments. (D) Luciferase assay. 
pmiR-Reports containing the wild type (Wnt1-3’UTR) or mutated (Wnt1-3’UTRmut) 3’untranslated 
sequence for Wnt1 were co-transfected with Tet-O-FUW-miR-34b/c plus rtTA (miR-34b/c), Tet-O-
FUW-miR-148a-3p plus rtTA (miR-148a). The empty pmiR-Report vector was used as additional 
control. All luciferase data have been normalized to the Renilla (RL-SV40) activity. Data represent 
mean± s.e.m. from three independent experiments. *, P<0.01 (Student’s t-test). (E) Dual-fluorescent 
reporter assay based on green fluorescent protein-reporter (GFP) and monomeric red fluorescent 
protein sensor (mRFP). Left columns: ES cells transfected with a plasmid containing a 
complementary sequence to the miR-34b/c downstream the CDS for the mRFP sensor (pDSV3-34) 
or with a plasmid containing a sequence mutated in the region corresponding to the “seed” for miR-
34b/c (pDSV3-34mut). Right columns: ES cells transfected with a plasmid containing the wild type 
Wnt1-3’UTR (pDSV2-UTR) or mutated in the binding site for miR-34b/c (pDSV3-UTRmut) 
downstream the CDS for the mRFP-sensor. Images were acquired 72 hours after transfection. Scale 
bar is 50 µm 
Figure 4 – The expression of miR-34b/c in ES cells promotes DA differentiation by down-
regulating Wnt signaling. (A) Schematic representation of the experimental procedure: mES cells 
were infected with an inducible lentiviral vector expressing miR-34b/c upstream an IRES-GFP 
sequence. Cells were FACS purified, amplified and differentiated towards the DA phenotype. (B) 
TaqMan assay for miR-34c in sorted mES cells in presence or absence of doxycycline (DOX). Data 
have been normalized to the average of the reference sno-202. Data represent mean± s.e.m. *, P<0.01 
(Student’s t-test). (C-D) qPCR analysis for genes related to the wnt pathway such as Wnt1, Lmx1b, 
Axin2 and Lef1 and for the expression of dopaminergic genes such as TH, Vmat2, DAT, and Pitx3 
at d14 MD in presence or absence of doxycycline. Data represent mean± s.e.m. from three 
independent experiments; *, P<0.01 (Student’s t-test). (E) Immunostaining and relative 
quantifications for TH in mES at d14 MD. Counting was performed from 20 randomly selected fields 
for each condition, of three independent experiments. Data represent mean ± s.e.m. *, P<0.05 relative 
to -DOX (Student’s t-test). A higher magnification image of DA-differentiated ES cells is shown in 
F. TH (red) and Tubb3 (green). Scale bar are: 200 µm in (E) and 100 µm in (F).   
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Figure 5 – miR-34b/c increases dopaminergic transdifferentiation. (A) FAC sorting of MEF, 
derived from TH-GFP mice, transdifferentiated into DA neurons (iDA) with Ascl1 and Nurr1 (AN) 
or Ascl1, Nurr1 and miR-34b/c (AN34). The percentage of TH-GFP+ cells is shown in (B). (C-D) 
Representative pictures of iDA obtained with AN, AN34 or AN34 plus CHIR99021 (AN34C) a 
potent activator of the Wnt pathway and relative quantification (D). Scale bar is 100µm. A 
representative image of iDA neurons obtained with AN34 is shown in (E); TH is in green, Tubb3 in 
red. Scale bar is 25 µm. (F-G) qPCR for Wnt1 and its downstream target Lef1 of MEF 
transdifferentiated with Ascl1 alone (A), Ascl1 and Nurr1 (AN) or Ascl1, Nurr1 and miR-34b/c in 
presence or not of chiron (AN34 or AN34C). (H-J) qPCR for the expression of dopaminergic genes 
such as TH, DAT and Vmat2 in iDA obtained with AN, AN34 or AN34C. qPCR data for gene 
expression have been normalized to the average of the reference gene Hmbs. Data represent mean± 
s.e.m. from three independent experiments *, P<0.01 (Newmann-Keuls test).  
Figure 6 – miR-34b/c derived iDA cells are functionally active. (A) MEF derived from TH-GFP 
mice, trans-differentiated in presence of AN or AN34 and immunostained with and anti-DA antibody. 
Arrowheads indicate double positive (DA+;GFP+) cells. Quantification of DA+;GFP+ is shown in (B). 
(C) Spontaneous firing activity of iDA neurons during extracellular single-unit recording is reversibly 
inhibited by TTX. In whole cell recordings, injection of depolarizing current steps from a holding 
potential of -54 mV evoked trains of action potentials (D, left) that were blocked by TTX (D, right), 
suggesting that they are mediated by fast Na+ currents. Hyperpolarization-activated membrane 
currents (E) and sag potentials (F) indicate the expression of Ih current in iDA neurons. Typical 
voltage-dependent inward and outward currents (G) are also present in iDA neurons. 
 
 
